Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Livraghi, T.
Right arrow Articles by Lazzaroni, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Livraghi, T.
Right arrow Articles by Lazzaroni, S.

Radiology, Vol 179, 709-712, Copyright © 1991 by Radiological Society of North America

ARTICLES

Liver metastases: results of percutaneous ethanol injection in 14 patients

T Livraghi, C Vettori and S Lazzaroni
Department of Radiology, Ospedale Civile, Milan, Italy.

Percutaneous ethanol injection (PEI) was performed under ultrasound (US) guidance in the outpatient department in 14 patients with 21 metastases 1.0-3.8 cm in diameter. The primary cancer was colorectal adenocarcinoma (seven patients), adenocarcinoma of the stomach (four patients), abdominal leiomyosarcoma (one patient), gastrinoma of unknown origin (one patient), and bronchial carcinoid (one patient). The indicators of therapeutic efficacy were US, computed tomography, fine-needle biopsy, and serologic markers. No complications occurred after a total of 175 treatment sessions. Complete response was obtained in 11 lesions, nine of which were less than 2 cm in diameter, and in all endocrine metastases (four lesions in two patients) with a maximum, recurrence-free follow-up of 38 months. Carcinoembryonic antigen values decreased in all patients but one for a 2-6-month period. The natural course of metastatic disease strictly limits the applicability of PEI, a local treatment. Single, metachronous, nonoperable metastasis of adenocarcinoma and endocrine metastases seem to be the only indications for PEI.


This article has been cited by other articles:


Home page
 RadioGraphicsHome page
M. J. Steward, V. S. Warbey, A. Malhotra, M. E. Caplin, J. R. Buscombe, and D. Yu
Neuroendocrine Tumors: Role of Interventional Radiology in Therapy
RadioGraphics, July 1, 2008; 28(4): 1131 - 1145.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
T. de Baere, B. Bessoud, C. Dromain, M. Ducreux, V. Boige, N. Lassau, T. Smayra, B. V. Girish, A. Roche, and D. Elias
Percutaneous Radiofrequency Ablation of Hepatic Tumors During Temporary Venous Occlusion
Am. J. Roentgenol., January 1, 2002; 178(1): 53 - 59.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
J. P. McGahan and G. D. Dodd III
Radiofrequency Ablation of the Liver: Current Status
Am. J. Roentgenol., January 1, 2001; 176(1): 3 - 16.
[Full Text]

Home page
 Cancer Res.Home page
Marco Del Governatore, M. R. Hamblin, C. R. Shea, I. Rizvi, K. G. Molpus, K. K. Tanabe, and T. Hasan
Experimental Photoimmunotherapy of Hepatic Metastases of Colorectal Cancer with a 17.1A Chlorine6 Immunoconjugate
Cancer Res., August 1, 2000; 60(15): 4200 - 4205.
[Abstract] [Full Text]

Home page
 BMJHome page
A. Cuschieri
Technology for minimal access surgery
BMJ, November 13, 1999; 319(7220): 1304 - 1304.
[Full Text]

Home page
 Palliat MedHome page
S. N Jones
Interventional radiology in a palliative care setting
Palliative Medicine, October 1, 1995; 9(4): 319 - 326.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1991 by the Radiological Society of North America.